Evan H Zhang - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Cancer Letters|April 4, 2021

Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthaseChao J Wang, Deren Li, Jacob A Danielson, et al.

Cancer Research Communications|October 27, 2023

SIX4 Controls Anti-PD-1 Efficacy by Regulating STING ExpressionBeiyuan Liang, Evan H Zhang, Zhen Ye, et al.

Molecular Cancer Therapeutics|October 9, 2024

Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal CancerBeiyuan Liang, Misbah Khan, Hayden Storts, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2025

Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical TrialChunjie Li, Anne M Noonan, John Hays, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Cancer Letters|April 4, 2021

Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthaseChao J Wang, Deren Li, Jacob A Danielson, et al.

Cancer Research Communications|October 27, 2023

SIX4 Controls Anti-PD-1 Efficacy by Regulating STING ExpressionBeiyuan Liang, Evan H Zhang, Zhen Ye, et al.

Molecular Cancer Therapeutics|October 9, 2024

Riluzole Enhancing Anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal CancerBeiyuan Liang, Misbah Khan, Hayden Storts, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2025

Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical TrialChunjie Li, Anne M Noonan, John Hays, et al.

Pageof 1